Targeting ferroptosis in breast cancer: mechanisms, biological functions, and natural product-related therapeutic strategies
Authors:
Open Access
- 7 April 2026
- journal article
- review article
- Published by Springer Nature in European Journal of Medical Research
- Vol. 31 (1)
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation funded project (2022M711722)
This publication has 171 references indexed in Scilit:
- Vanillin restrains proliferation of triple negative breast cancer cells by inducing ferroptosis via mediating the KLF2/GPX4 axisCytotechnology, 2025
- HER2-Positive Breast Cancer Treatment and Resistance2025
- TYMS Knockdown Suppresses Cells Proliferation, Promotes Ferroptosis via Inhibits PI3K/Akt/mTOR Signaling Pathway Activation in Triple Negative Breast CancerCell Biochemistry and Biophysics, 2024
- Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumorsMedical Oncology, 2023
- Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast CancerCurrent Treatment Options in Oncology, 2023
- Iron Homeostasis and Metabolism: Two Sides of a Coin2021
- Farnesoid X Receptor Activation Impairs Liver Progenitor Cell–Mediated Liver Regeneration via the PTEN‐PI3K‐AKT‐mTOR Axis in ZebrafishHepatology, 2021
- Targeting the PI3K/AKT/mTOR Pathway in Hormone-Positive Breast CancerDrugs, 2020
- Lipid Droplets in Cancer2020
- Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapyProtein & Cell, 2020